Cargando…

Using Novel Statistical Techniques to Accurately Determine the Predictive Dose Range in a Study of Overall Survival after Definitive Radiotherapy for Stage III Non-Small Cell Lung Cancer in Association with Heart Dose

PURPOSE: Recent studies of radiotherapy (RT) for stage III non-small-cell lung cancer (NSCLC) have associated high dose to the heart with cardiac toxicity and decreased overall survival (OS). We used advanced statistical techniques to account for correlations between dosimetric variables and more ac...

Descripción completa

Detalles Bibliográficos
Autores principales:	Niska, Joshua R., Hu, Jiuyun, Li, Jing, Herman, Michael G., Thorpe, Cameron S., Schild, Steven E., Fatyga, Mirek
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8601657/ https://www.ncbi.nlm.nih.gov/pubmed/34804634 http://dx.doi.org/10.4236/jct.2021.129044

Ejemplares similares

Impact of Cardiac Dose on Overall Survival in Lung Stereotactic Body Radiotherapy (SBRT) Compared to Conventionally Fractionated Radiotherapy for Locally Advanced Non-Small Cell Lung Cancer (LA-NSCLC)
por: Anderson, Justin D., et al.
Publicado: (2021)

Benzodiazepine high‐doses: The need for an accurate definition
por: Cloos, Jean‐Marc, et al.
Publicado: (2021)

Statins and Metformin Use Is Associated with Lower PSA Levels in Prostate Cancer Patients Presenting for Radiation Therapy
por: Liu, Xiaonan, et al.
Publicado: (2017)

Machine Learning of Dose-Volume Histogram Parameters Predicting Overall Survival in Patients with Cervical Cancer Treated with Definitive Radiotherapy
por: Xu, Zhiyuan, et al.
Publicado: (2022)

Dose–Response of TLD-100 in the Dose Range Useful for Hypofractionated Radiotherapy
por: Liuzzi, Raffaele, et al.
Publicado: (2020)

Biologically Effective Dose and Rectal Bleeding in Definitive Proton Therapy for Prostate Cancer
por: Bhangoo, Ronik S., et al.
Publicado: (2021)

Modeling of Acute Rectal Toxicity to Compare Two Patient Positioning Methods for Prostate Cancer Radiotherapy: Can Toxicity Modeling be Used for Quality Assurance?
por: Liu, X, et al.
Publicado: (2018)

Impact of planned dose reporting methods on Gamma pass rates for IROC lung and liver motion phantoms treated with pencil beam scanning protons
por: Kang, Yixiu, et al.
Publicado: (2019)

Patient Specific Characteristics Are an Important Factor That Determines the Risk of Acute Grade ≥ 2 Rectal Toxicity in Patients Treated for Prostate Cancer with IMRT and Daily Image Guidance Based on Implanted Gold Markers
por: Liu, Xiaonan, et al.
Publicado: (2016)

Optimal Radiation Dose for Stage III Lung Cancer—Should “Definitive” Radiation Doses Be Used in the Preoperative Setting?
por: Saffarzadeh, Areo G., et al.
Publicado: (2021)

Definitive radiotherapy dose escalation with chemotherapy for treating non-metastatic oesophageal cancer
por: Fan, Chao-Yueh, et al.
Publicado: (2018)

Accurate estimation of daily delivered radiotherapy dose with an external treatment planning system
por: Kanehira, Takahiro, et al.
Publicado: (2020)

Extending in aqua portal dosimetry with dose inhomogeneity conversion maps for accurate patient dose reconstruction in external beam radiotherapy
por: Olaciregui-Ruiz, Igor, et al.
Publicado: (2022)

Is internal target volume accurate for dose evaluation in lung cancer stereotactic body radiotherapy?
por: Peng, Jiayuan, et al.
Publicado: (2016)

Beyond exposure‐response: A tutorial on statistical considerations in dose‐ranging studies
por: Laird, Glen, et al.
Publicado: (2021)

Recommended dose voxel size and statistical uncertainty parameters for precision of Monte Carlo dose calculation in stereotactic radiotherapy
por: Goodall, Simon K., et al.
Publicado: (2020)

A Patients-Based Statistical Model of Radiotherapy Dose Distribution in Nasopharyngeal Cancer
por: Liu, Gang, et al.
Publicado: (2019)

Patient-reported quality-of-life outcomes in relation to provider-assessed adverse events during head and neck radiotherapy
por: Niska, Joshua R., et al.
Publicado: (2020)

Heart dose linked with cardiac events and overall survival in lung cancer radiotherapy: A meta-analysis
por: Pan, Li, et al.
Publicado: (2020)

Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy
por: Kim, Hyun Ju, et al.
Publicado: (2017)

EROS study: evaluation between high-dose-rate and low-dose-rate vaginal interventional radiotherapy (brachytherapy) in terms of overall survival and rate of stenosis
por: Autorino, Rosa, et al.
Publicado: (2018)

A ‘Hybrid’ Radiotherapy Regimen Designed for Immunomodulation: Combining High-Dose Radiotherapy with Low-Dose Radiotherapy
por: Ji, Hongshan, et al.
Publicado: (2022)

The Impact of Lymphopenia and Dosimetric Parameters on Overall Survival of Esophageal Cancer Patients Treated with Definitive Radiotherapy
por: Liu, Ming, et al.
Publicado: (2021)

Locally dose-escalated radiotherapy may improve intracranial local control and overall survival among patients with glioblastoma
por: Zschaeck, Sebastian, et al.
Publicado: (2018)

Dynamics-Adapted Radiotherapy Dose (DARD) for Head and Neck Cancer Radiotherapy Dose Personalization
por: Zahid, Mohammad U., et al.
Publicado: (2021)

Higher Radiation Dose to the Immune Cells Correlates with Worse Tumor Control and Overall Survival in Patients with Stage III NSCLC: A Secondary Analysis of RTOG0617
por: Jin, Jian-Yue, et al.
Publicado: (2021)

Evaluating the optimal re-irradiation dose for locally recurrent esophageal squamous cell carcinoma after definitive radiotherapy
por: Xu, Xiujuan, et al.
Publicado: (2019)

Relationship between dosimetric leaf gap and dose calculation errors for high definition multi-leaf collimators in radiotherapy
por: Kim, Jinkoo, et al.
Publicado: (2018)

Whether individualized dose escalation should be recommended for lymph nodes with different sizes in the definitive radiotherapy of cervical cancer?
por: Lv, Xiaojuan, et al.
Publicado: (2022)

Effect of modern high-dose versus standard-dose radiation in definitive concurrent chemo-radiotherapy on outcome of esophageal squamous cell cancer: a meta-analysis
por: Luo, He-San, et al.
Publicado: (2019)

Dose escalation of radiotherapy in unresectable extrahepatic cholangiocarcinoma
por: Elganainy, Dalia, et al.
Publicado: (2018)

Dose-response relationship for breast cancer induction at radiotherapy dose
por: Schneider, Uwe, et al.
Publicado: (2011)

Modeling of kyphoplasty cement for accurate dose calculations
por: Halvorsen, Per H., et al.
Publicado: (2021)

Low-Dose Radiotherapy Versus Moderate-Dose Radiotherapy for the Treatment of Indolent Orbital Adnexal Lymphomas
por: Baron, Jonathan, et al.
Publicado: (2021)

High-dose stereotactic body radiotherapy correlates increased local control and overall survival in patients with inoperable hepatocellular carcinoma
por: Jang, Won Il, et al.
Publicado: (2013)

Contrast-Enhanced Magnetic Resonance Angiography: Dose the Test Dose Bolus Represent the Main Dose Bolus Accurately?
por: Lee, Jongmin J., et al.
Publicado: (2000)

The impact of increasing dose on overall survival in prostate cancer
por: Hall, Matthew D., et al.
Publicado: (2015)

Dose delivery reproducibility for PBS proton treatment of breast cancer patients with and without mask immobilization
por: Kang, Yixiu, et al.
Publicado: (2023)

Definitive high-dose radiotherapy with concurrent chemotherapy for locally advanced rectal cancer: A case report and literature review
por: Kim, Min-Jeong, et al.
Publicado: (2016)

Accurate and Fast Deep Learning Dose Prediction for a Preclinical Microbeam Radiation Therapy Study Using Low-Statistics Monte Carlo Simulations
por: Mentzel, Florian, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_ku267ongujon369aglc2oried4